LIVZON PHARMAC (Germany) Performance
| LP6 Stock | EUR 3.22 0.06 1.90% |
On a scale of 0 to 100, LIVZON PHARMAC holds a performance score of 7. The company secures a Beta (Market Risk) of 0.62, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LIVZON PHARMAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding LIVZON PHARMAC is expected to be smaller as well. Please check LIVZON PHARMAC's treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to make a quick decision on whether LIVZON PHARMAC's current price movements will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in LIVZON PHARMAC GRP are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, LIVZON PHARMAC reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 11.1852 | |
| Dividend Yield | 0.0594 | |
| Payout Ratio | 0.6547 |
LIVZON |
LIVZON PHARMAC Relative Risk vs. Return Landscape
If you would invest 278.00 in LIVZON PHARMAC GRP on September 12, 2024 and sell it today you would earn a total of 44.00 from holding LIVZON PHARMAC GRP or generate 15.83% return on investment over 90 days. LIVZON PHARMAC GRP is currently producing 0.2637% returns and takes up 2.6003% volatility of returns over 90 trading days. Put another way, 23% of traded stocks are less volatile than LIVZON, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
LIVZON PHARMAC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LIVZON PHARMAC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LIVZON PHARMAC GRP, and traders can use it to determine the average amount a LIVZON PHARMAC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LP6 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.6 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average LIVZON PHARMAC is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LIVZON PHARMAC by adding it to a well-diversified portfolio.
LIVZON PHARMAC Fundamentals Growth
LIVZON Stock prices reflect investors' perceptions of the future prospects and financial health of LIVZON PHARMAC, and LIVZON PHARMAC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LIVZON Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0514 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.15 % | |||
| Shares Outstanding | 309.83 M | |||
| Price To Earning | 4.02 X | |||
| Revenue | 12.18 B | |||
| EBITDA | 2.3 B | |||
| Cash And Equivalents | 1.14 B | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 22.97 M | |||
| Debt To Equity | 1.30 % | |||
| Book Value Per Share | 14.37 X | |||
| Cash Flow From Operations | 192.47 M | |||
| Earnings Per Share | 0.27 X | |||
About LIVZON PHARMAC Performance
By analyzing LIVZON PHARMAC's fundamental ratios, stakeholders can gain valuable insights into LIVZON PHARMAC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LIVZON PHARMAC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LIVZON PHARMAC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people.Things to note about LIVZON PHARMAC GRP performance evaluation
Checking the ongoing alerts about LIVZON PHARMAC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LIVZON PHARMAC GRP help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 53.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing LIVZON PHARMAC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LIVZON PHARMAC's stock is overvalued or undervalued compared to its peers.
- Examining LIVZON PHARMAC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LIVZON PHARMAC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LIVZON PHARMAC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LIVZON PHARMAC's stock. These opinions can provide insight into LIVZON PHARMAC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LIVZON Stock analysis
When running LIVZON PHARMAC's price analysis, check to measure LIVZON PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIVZON PHARMAC is operating at the current time. Most of LIVZON PHARMAC's value examination focuses on studying past and present price action to predict the probability of LIVZON PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIVZON PHARMAC's price. Additionally, you may evaluate how the addition of LIVZON PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |